Use of bovine hydroxyapatite with or without biomembrane in sinus lift in rabbits: histopathologic analysis and immune expression of core binding factor 1 and vascular endothelium growth factor

J Oral Maxillofac Surg. 2011 Apr;69(4):1064-9. doi: 10.1016/j.joms.2010.02.057. Epub 2010 Aug 19.

Abstract

Purpose: Considering the clinical discussion on the necessity of using a barrier membrane in the osteotomy area of sinus lift procedures to prevent fibrous tissue formation in this area and as a physical limit, the aim of this study was to analyze and compare the use of bovine hydroxyapatite (HA) with and without a biologic membrane by histopathologic analysis and immune expression of core binding factor 1 and vascular endothelium growth factor in the sinus lift in rabbits.

Materials and methods: Sixteen male rabbits underwent bilateral sinus lift procedures and were divided into 2 groups according to the sinus filling material: group 1 received bovine HA (Bio-Oss; Geistlich Pharma AG, Wohlhusen, Switzerland) and group 2 received bovine HA and a nonporous polytetrafluorethylene membrane. All groups were sacrificed after 7, 14, 30, and 60 days for microscopic, histomorphometric, and immunohistochemical analyses.

Results: Microscopic analysis showed a similar bone repair pattern between the tested groups. New bone formation, soft tissue, and the remaining material were analyzed by histomorphometric analysis. No statistically significant differences (P > .05) were detected between groups for all periods analyzed. In addition, no remarkable differences were noticed in core binding factor 1 or vascular endothelium growth factor immune expression.

Conclusion: Taken together, these results show that using a biologic membrane does not improve bone repair induced by bovine HA, as shown by histopathologic and immunohistochemical analyses.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alveolar Ridge Augmentation / methods*
  • Animals
  • Biocompatible Materials / therapeutic use*
  • Bone Matrix / transplantation
  • Bone Substitutes / therapeutic use*
  • Cattle
  • Connective Tissue / pathology
  • Core Binding Factor Alpha 1 Subunit / analysis*
  • Durapatite / therapeutic use*
  • Granulation Tissue / pathology
  • Image Processing, Computer-Assisted
  • Immunohistochemistry
  • Male
  • Maxilla / pathology
  • Maxilla / surgery*
  • Maxillary Sinus / pathology
  • Maxillary Sinus / surgery*
  • Membranes, Artificial*
  • Minerals / therapeutic use
  • Osteogenesis / physiology
  • Osteotomy / methods
  • Polytetrafluoroethylene
  • Rabbits
  • Time Factors
  • Vascular Endothelial Growth Factor A / analysis*

Substances

  • Bio-Oss
  • Biocompatible Materials
  • Bone Substitutes
  • Core Binding Factor Alpha 1 Subunit
  • Membranes, Artificial
  • Minerals
  • Vascular Endothelial Growth Factor A
  • Polytetrafluoroethylene
  • Durapatite